A novel RNA variant of human concentrative nucleoside transporter 1 (hCNT1) that is a potential cancer biomarker

por Wang, Chunmei, Buolamwini, John K.
Publicado 2019

Inhibiting β-Catenin by β-Carboline-Type MDM2 Inhibitor for Pancreatic Cancer Therapy

por Qin, Jiang-Jiang, Wang, Wei, Li, Xin, Deokar, Hemantkumar, Buolamwini, John K., Zhang, Ruiwen
Publicado 2018

JKA97, a Novel Benzylidene Analog of Harmine, Exerts Anti-Cancer Effects by Inducing G1 Arrest, Apoptosis, and p53-Independent Up-Regulation of p21

por Yang, Xinyi, Wang, Wei, Qin, Jiang-Jiang, Wang, Ming-Hai, Sharma, Horrick, Buolamwini, John K., Wang, Hui, Zhang, Ruiwen
Publicado 2012

Targeted Brain Tumor Therapy by Inhibiting the MDM2 Oncogene: In Vitro and In Vivo Antitumor Activity and Mechanism of Action

por Punganuru, Surendra R., Arutla, Viswanath, Zhao, Wei, Rajaei, Mehrdad, Deokar, Hemantkumar, Zhang, Ruiwen, Buolamwini, John K., Srivenugopal, Kalkunte S., Wang, Wei
Publicado 2020

Synthesis, Biological Evaluation and Modeling Studies of New Pyrido[3,4-b]indole Derivatives as Broad-Spectrum Potent Anticancer Agents

por Patil, Shivaputra A, Addo, James K, Deokar, Hemantkumar, Sun, Shan, Wang, Jin, Li, Wei, Suttle, D Parker, Wang, Wei, Zhang, Ruiwen, Buolamwini, John K
Publicado 2017

Targeting MDM2 for Neuroblastoma Therapy: In Vitro and In Vivo Anticancer Activity and Mechanism of Action

por Wang, Wei, Wang, Xinjie, Rajaei, Mehrdad, Youn, Ji Youn, Zafar, Atif, Deokar, Hemantkumar, Buolamwini, John K., Yang, Jianhua, Foster, Jennifer H., Zhou, Jia, Zhang, Ruiwen
Publicado 2020